Eikon Therapeutics
Roger Perlmutter was the President of Merck Research Laboratories from April 2013 to December 2020. Roger is currently the CEO of Eikon Therapeutics.
Dan Anderson - Chief Scientific Officer, Ashish Kheterpal - Chief Information Officer, and Russ Berman - Chief Technical Officer report to Roger Perlmutter.
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.